Vitros XT7600 reagents
Ended Awarded Last action
- Contract number
- W81K0225FA007
- Awardee
-
Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch UEI JNSJRDQQH2J6
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $99,017
Award facts
- Contract value 100% obligated
- $99,017.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$22,453 | |
| Original award | $121,470 |
About this award
The Defense Health Agency awarded a $99,017 firm fixed-price delivery order to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch for VITROS XT7600 reagents, with performance completion scheduled for September 30, 2025. This delivery order was issued under an existing $1.25 million indefinite delivery contract established on February 1, 2025, which extends through September 30, 2026. The underlying IDV was structured as a sole-source procurement under Federal Acquisition Regulation 13.501(a)(1)(ii), reflecting the contractor's status as the only viable source capable of meeting the specific technical and compatibility requirements for VITROS XT7600 reagent supplies. The place of performance is South Korea, where the contractor supplies critical diagnostic consumables to support U.S. military medical operations.
Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch, headquartered in Seoul, is a for-profit medical equipment manufacturer and supplier specializing in laboratory diagnostic systems and consumables for the Department of Defense. The company has demonstrated substantial experience supporting military healthcare operations across the Asia-Pacific region, with approximately $5.7 million in cumulative prime contract value from the Defense Health Agency, Pacific Air Forces, and Army Medical Command. This contract award carries no set-aside designation and reflects the contractor's established role as a critical supplier of VITROS diagnostic equipment and reagents to U.S. military medical facilities, including Camp Humphreys and Osan Air Base.
Quick answers
Who was awarded contract W81K0225FA007?
W81K0225FA007 was awarded to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch by Medical Command (Department of the Army) on February 1, 2025.
How much is contract W81K0225FA007 worth?
The government has obligated $99,017 on W81K0225FA007.
Which agency awarded contract W81K0225FA007?
Medical Command (Department of the Army) awarded W81K0225FA007, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0225FA007 an order under another contract?
Yes. W81K0225FA007 is a delivery order under W81K0225DA003, an indefinite delivery contract.
Was contract W81K0225FA007 competed?
The extent of competition for W81K0225FA007 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award